Direct interplay between two candidate genes in FSHD muscular dystrophy

Human Molecular Genetics

Volumn 24, Issue 5, 2015, Pages 1256-1266

  Ferri, Giulia ^a,b   Huichalaf, Claudia H ^a,b   Caccia, Roberta ^a   Gabellini, Davide ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FRG1 PROTEIN; PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR DUX4; UNCLASSIFIED DRUG; CHROMATIN; DUX4 PROTEIN, HUMAN; DUX4 PROTEIN, MOUSE; FRG1 PROTEIN, HUMAN; FRG1 PROTEIN, MOUSE; HOMEODOMAIN PROTEIN; NUCLEAR PROTEIN;

AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING SITE; CHROMATIN IMMUNOPRECIPITATION; CONSENSUS SEQUENCE; CONTROLLED STUDY; ELECTROPORATION; ENHANCER REGION; EXPRESSION VECTOR; FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; GENE INTERACTION; GENETIC ASSOCIATION; HIGH THROUGHPUT SEQUENCING; HUMAN; HUMAN CELL; LUCIFERASE ASSAY; MALE; MOUSE; MUSCLE CELL; MYOBLAST; NONHUMAN; NUCLEOTIDE SEQUENCE; OLIGONUCLEOTIDE PROBE; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSACTIVATION; TRANSCRIPTION INITIATION; UPREGULATION; ANIMAL; CELL LINE; CHROMATIN; COPY NUMBER VARIATION; CYTOLOGY; GENE DELETION; GENE LOCUS; GENETICS; HEK293 CELL LINE; METABOLISM; MIDDLE AGED; MOLECULAR CLONING; PATHOLOGY; SKELETAL MUSCLE; TRANSGENIC MOUSE;

MUS MUSCULUS;

AGED; ANIMALS; CELL LINE; CHROMATIN; CLONING, MOLECULAR; DNA COPY NUMBER VARIATIONS; GENE DELETION; GENETIC LOCI; HEK293 CELLS; HOMEODOMAIN PROTEINS; HUMANS; MALE; MICE; MICE, TRANSGENIC; MIDDLE AGED; MUSCLE CELLS; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL; MYOBLASTS; NUCLEAR PROTEINS; PROTEINS; UP-REGULATION;

EID: 84924514159     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddu536     Document Type: Article

References (62)

1. Cabianca, D.S. and Gabellini, D. (2010) The cell biology of disease: FSHD: copy number variations on the theme of muscular dystrophy. J. Cell. Biol., 191, 1049-1060.
2. Deenen, J.C., Arnts, H., van der Maarel, S.M., Padberg, G.W., Verschuuren, J.J., Bakker, E., Weinreich, S.S., Verbeek, A.L. and van Engelen, B.G. (2014) Population-based incidence and prevalence of facioscapulohumeral dystrophy. Neurology., 83, 1056-1059.
3. Pandya, S., King,W.M. and Tawil, R. (2008) Facioscapulohumeral dystrophy. Phys. Ther., 88, 105-113.
4. Wijmenga, C., Frants, R.R., Brouwer, O.F., Moerer, P.,Weber, J. L. and Padberg, G.W. (1990) Location of facioscapulohumeral muscular dystrophy gene on chromosome 4. Lancet, 336, 651-653.
5. van Deutekom, J.C., Wijmenga, C., van Tienhoven, E.A., Gruter, A.M., Hewitt, J.E., Padberg, G.W., van Ommen, G.J., Hofker, M.H. and Frants, R.R. (1993) FSHD associated DNA rearrangements are due to deletions of integral copies of a 3.2 kb tandemly repeated unit. Hum. Mol. Genet., 2, 2037-2042.
6. Cabianca, D.S., Casa, V., Bodega, B., Xynos, A., Ginelli, E., Tanaka, Y. and Gabellini, D. (2012) A long ncRNA links copy number variation to a polycomb/trithorax epigenetic switch in FSHD muscular dystrophy. Cell, 149, 819-831.
7. Gabellini, D., Green, M.R. and Tupler, R. (2002) Inappropriate gene activation in FSHD: a repressor complex binds a chromosomal repeat deleted in dystrophic muscle. Cell, 110, 339-348.
8. Rijkers, T., Deidda, G., van Koningsbruggen, S., van Geel, M., Lemmers, R.J., van Deutekom, J.C., Figlewicz, D., Hewitt, J.E., Padberg, G.W., Frants, R.R. et al. (2004) FRG2, an FSHD candidate gene, is transcriptionally upregulated in differentiating primary myoblast cultures of FSHD patients. J. Med. Genet., 41, 826-836.
9. Laoudj-Chenivesse, D., Carnac, G., Bisbal, C., Hugon, G., Bouillot, S., Desnuelle, C., Vassetzky, Y. and Fernandez, A. (2005) Increased levels of adenine nucleotide translocator 1 protein and response to oxidative stress are early events in facioscapulohumeral muscular dystrophy muscle. J. Mol. Med., 83, 216-224.
10. Dixit, M., Ansseau, E., Tassin, A.,Winokur, S., Shi, R., Qian, H., Sauvage, S., Matteotti, C., van Acker, A.M., Leo, O. et al. (2007) DUX4, a candidate gene of facioscapulohumeral muscular dystrophy, encodes a transcriptional activator of PITX1. Proc. Natl. Acad. Sci. USA, 104, 18157-18162.
11. Ansseau, E., Laoudj-Chenivesse, D., Marcowycz, A., Tassin, A., Vanderplanck, C., Sauvage, S., Barro, M., Mahieu, I., Leroy, A., Leclercq, I. et al. (2009) DUX4c is up-regulated in FSHD. It induces the MYF5 protein and human myoblast proliferation. PLoS One, 4, e7482.
12. Lemmers, R.J., van der Vliet, P.J., Klooster, R., Sacconi, S., Camano, P., Dauwerse, J.G., Snider, L., Straasheijm, K.R., van Ommen, G.J., Padberg, G.W. et al. (2010) A unifying genetic model for facioscapulohumeral muscular dystrophy. Science, 329, 1650-1653.
13. Snider, L., Geng, L.N., Lemmers, R.J., Kyba, M.,Ware, C.B., Nelson, A.M., Tawil, R., Filippova, G.N., van der Maarel, S.M., Tapscott, S.J. et al. (2010) Facioscapulohumeral dystrophy: incomplete suppression of a retrotransposed gene. PLoS Genet., 6, e1001181.
14. Neguembor, M.V., Xynos, A., Onorati, M.C., Caccia, R., Bortolanza, S., Godio, C., Pistoni, M., Corona, D.F., Schotta, G. and Gabellini, D. (2013) FSHD muscular dystrophy region gene 1 binds Suv4-20h1 histone methyltransferase and impairs myogenesis. J. Mol. Cell Biol., 5, 294-307.
15. Caruso, N., Herberth, B., Bartoli, M., Puppo, F., Dumonceaux, J., Zimmermann, A., Denadai, S., Lebosse, M., Roche, S., Geng, L. et al. (2013) Deregulation of the protocadherin gene FAT1 alters muscle shapes: implications for the pathogenesis of facioscapulohumeral dystrophy. PLoS Genet., 9, e1003550.
16. Broucqsault, N., Morere, J., Gaillard, M.C., Dumonceaux, J., Torrents, J., Salort-Campana, E., Maues De Paula, A., Bartoli, M., Fernandez, C., Chesnais, A.L. et al. (2013) Dysregulation of 4q35- and muscle-specific genes in fetuses with a short D4Z4 array linked to facio-scapulo-humeral dystrophy. Hum. Mol. Genet., 22, 4206-4214.
17. Winokur, S.T., Barrett, K., Martin, J.H., Forrester, J.R., Simon, M., Tawil, R., Chung, S.A., Masny, P.S. and Figlewicz, D.A. (2003) Facioscapulohumeral muscular dystrophy (FSHD) myoblasts demonstrate increased susceptibility to oxidative stress. Neuromuscul. Disord., 13, 322-333.
18. Tsumagari, K., Chang, S.C., Lacey, M., Baribault, C., Chittur, S. V., Sowden, J., Tawil, R., Crawford, G.E. and Ehrlich, M. (2011) Gene expression during normal and FSHD myogenesis. BMC Med Genomics, 4, 67.
19. Winokur, S.T., Chen, Y.W., Masny, P.S., Martin, J.H., Ehmsen, J. T., Tapscott, S.J., van der Maarel, S.M., Hayashi, Y. and Flanigan, K.M. (2003) Expression profiling of FSHD muscle supports a defect in specific stages of myogenic differentiation. Hum. Mol. Genet., 12, 2895-2907.
20. Jiang, G., Yang, F., van Overveld, P.G., Vedanarayanan, V., van der Maarel, S. and Ehrlich, M. (2003) Testing the positioneffect variegation hypothesis for facioscapulohumeral muscular dystrophy by analysis of histone modification and gene expression in subtelomeric 4q. Hum. Mol. Genet., 12, 2909-2921.
21. Klooster, R., Straasheijm, K., Shah, B., Sowden, J., Frants, R., Thornton, C., Tawil, R. and van der Maarel, S. (2009) Comprehensive expression analysis of FSHD candidate genes at the mRNA and protein level. Eur. J. Hum. Genet., 17, 1615-1624.
22. Masny, P.S., Chan, O.Y., de Greef, J.C., Bengtsson, U., Ehrlich, M., Tawil, R., Lock, L.F., Hewitt, J.E., Stocksdale, J., Martin, J. H. et al. (2010) Analysis of allele-specific RNA transcription in FSHD by RNA-DNA FISH in single myonuclei. Eur. J. Hum. Genet., 18, 448-456.
23. Arashiro, P., Eisenberg, I., Kho, A.T., Cerqueira, A.M., Canovas, M., Silva, H.C., Pavanello, R.C., Verjovski-Almeida, S., Kunkel, L.M. and Zatz, M. (2009) Transcriptional regulation differs in affected facioscapulohumeral muscular dystrophy patients compared to asymptomatic related carriers. Proc. Natl. Acad. Sci. USA, 106, 6220-6225.
24. Osborne, R.J., Welle, S., Venance, S.L., Thornton, C.A. and Tawil, R. (2007) Expression profile of FSHD supports a link between retinal vasculopathy and muscular dystrophy. Neurology, 68, 569-577.
25. Snider, L., Asawachaicharn, A., Tyler, A.E., Geng, L.N., Petek, L.M., Maves, L., Miller, D.G., Lemmers, R.J., Winokur, S.T., Tawil, R. et al. (2009) RNA transcripts, miRNA-sized fragments and proteins produced from D4Z4 units: new candidates for the pathophysiology of facioscapulohumeral dystrophy. Hum. Mol. Genet., 18, 2414-2430.
26. Yao, Z., Snider, L., Balog, J., Lemmers, R.J., Van Der Maarel, S. M., Tawil, R. and Tapscott, S.J. (2014) DUX4-induced gene expression is the major molecular signature in FSHD skeletal muscle. Hum. Mol. Genet., 20, 5342-5352.
27. Jones, T.I., Chen, J.C., Rahimov, F., Homma, S., Arashiro, P., Beermann, M.L., King, O.D., Miller, J.B., Kunkel, L.M., Emerson, C.P. Jr. et al. (2012) Facioscapulohumeral muscular dystrophy family studies of DUX4 expression: evidence for disease modifiers and a quantitative model of pathogenesis. Hum. Mol. Genet., 21, 4419-4430.
28. Krom, Y.D., Thijssen, P.E., Young, J.M., den Hamer, B., Balog, J., Yao, Z., Maves, L., Snider, L., Knopp, P., Zammit, P.S. et al. (2013) Intrinsic epigenetic regulation of the D4Z4 macrosatellite repeat in a transgenic mouse model for FSHD. PLoS Genet., 9, e1003415.
29. Mitsuhashi, H., Mitsuhashi, S., Lynn-Jones, T., Kawahara, G. and Kunkel, L.M. (2012) Expression of DUX4 in zebrafish development recapitulates facioscapulohumeral muscular dystrophy. Hum. Mol. Genet., 3, 568-577.
30. van Deutekom, J.C., Lemmers, R.J., Grewal, P.K., van Geel, M., Romberg, S., Dauwerse, H.G.,Wright, T.J., Padberg, G.W., Hofker, M.H., Hewitt, J.E. et al. (1996) Identification of the first gene (FRG1) from the FSHD region on human chromosome 4q35. Hum. Mol. Genet., 5, 581-590.
31. Bodega, B., Ramirez, G.D., Grasser, F., Cheli, S., Brunelli, S., Mora, M., Meneveri, R., Marozzi, A., Mueller, S., Battaglioli, E. et al. (2009) Remodeling of the chromatin structure of the facioscapulohumeral muscular dystrophy (FSHD) locus and upregulation of FSHD-related gene 1 (FRG1) expression during human myogenic differentiation. BMC Biol., 7, 41.
32. Hanel, M.L., Sun, C.Y., Jones, T.I., Long, S.W., Zanotti, S., Milner, D. and Jones, P.L. (2011) Facioscapulohumeral muscular dystrophy (FSHD) region gene 1 (FRG1) is a dynamic nuclear and sarcomeric protein. Differentiation, 81, 107-118.
33. van Koningsbruggen, S., Dirks, R.W., Mommaas, A.M., Onderwater, J.J., Deidda, G., Padberg, G.W., Frants, R.R. and van der Maarel, S.M. (2004) FRG1P is localised in the nucleolus, Cajal bodies, and speckles. J. Med. Genet., 41, e46.
34. Sun, C.Y., van Koningsbruggen, S., Long, S.W., Straasheijm, K., Klooster, R., Jones, T.I., Bellini, M., Levesque, L., Brieher, W.M., van derMaarel, S.M. et al. (2011) Facioscapulohumeral muscular dystrophy region gene 1 is a dynamic RNAassociated and actin-bundling protein. J. Mol. Biol., 411, 397-416.
35. van Koningsbruggen, S., Straasheijm, K.R., Sterrenburg, E., de Graaf, N., Dauwerse, H.G., Frants, R.R. and van der Maarel, S. M. (2007) FRG1P-mediated aggregation of proteins involved in pre-mRNA processing. Chromosoma, 116, 53-64.
36. Gabellini, D., D'Antona, G., Moggio, M., Prelle, A., Zecca, C., Adami, R., Angeletti, B., Ciscato, P., Pellegrino, M.A., Bottinelli, R. et al. (2006) Facioscapulohumeral muscular dystrophy in mice overexpressing FRG1. Nature, 439, 973-977.
37. Pistoni, M., Shiue, L., Cline, M.S., Bortolanza, S., Neguembor, M.V., Xynos, A., Ares, M. Jr. and Gabellini, D. (2013) Rbfox1 downregulation and altered calpain 3 splicing by FRG1 in a mouse model of facioscapulohumeral muscular dystrophy (FSHD). PLoS Genet., 9, e1003186.
38. Sancisi, V., Germinario, E., Esposito, A., Morini, E., Peron, S., Moggio, M., Tomelleri, G., Danieli-Betto, D. and Tupler, R. (2014) Altered Tnnt3 characterizes selective weakness of fast fibers in mice overexpressing FSHD region gene 1 (FRG1). Am. J. Physiol. Regul. Integr. Comp. Physiol., 306, R124-R137.
39. Chen, S.C., Frett, E., Marx, J., Bosnakovski, D., Reed, X., Kyba, M. and Kennedy, B.K. (2011) Decreased proliferation kinetics of mouse myoblasts overexpressing FRG1. PLoS One, 6, e19780.
40. Xynos, A., Neguembor, M.V., Caccia, R., Licastro, D., Nonis, A., Di Serio, C., Stupka, E. and Gabellini, D. (2013) Overexpression of facioscapulohumeral muscular dystrophy region gene 1 causes primary defects in myogenic stem cells. J. Cell. Sci., 126, 2236-2245.
41. Hanel, M.L., Wuebbles, R.D. and Jones, P.L. (2009) Muscular dystrophy candidate gene FRG1 is critical for muscle development. Dev. Dyn. 238, 1502-1512.
42. Wuebbles, R.D., Hanel, M.L. and Jones, P.L. (2009) FSHD region gene 1 (FRG1) is crucial for angiogenesis linking FRG1 to facioscapulohumeral muscular dystrophy-associated vasculopathy. Dis. Model. Mech., 2, 267-274.
43. Liu, Q., Jones, T.I., Tang, V.W., Brieher, W.M. and Jones, P.L. (2010) Facioscapulohumeral muscular dystrophy region gene-1 (FRG-1) is an actin-bundling protein associated with muscle-attachment sites. J. Cell. Sci., 123, 1116-1123.
44. Geng, L.N., Yao, Z., Snider, L., Fong, A.P., Cech, J.N., Young, J. M., van der Maarel, S.M., Ruzzo, W.L., Gentleman, R.C., Tawil, R. et al. (2012) DUX4 activates germline genes, retroelements, and immune mediators: implications for facioscapulohumeral dystrophy. Dev. Cell., 22, 38-51.
45. Bonnefont, J., Nikolaev, S.I., Perrier, A.L., Guo, S., Cartier, L., Sorce, S., Laforge, T., Aubry, L., Khaitovich, P., Peschanski, M. et al. (2008) Evolutionary forces shape the human RFPL1,2,3 genes toward a role in neocortex development. Am. J. Hum. Genet., 83, 208-218.
46. Stanghellini, I., Falco, G., Lee, S.L., Monti, M. and Ko, M.S. (2009) Trim43a, Trim43b, and Trim43c: novel mouse genes expressed specifically in mouse preimplantation embryos. Gene Expr. Patterns, 9, 595-602.
47. Ferreboeuf, M., Mariot, V., Bessieres, B., Vasiljevic, A., Attie-Bitach, T., Collardeau, S., Morere, J., Roche, S., Magdinier, F., Robin-Ducellier, J. et al. (2014) DUX4 and DUX4 downstream target genes are expressed in fetal FSHD muscles. Hum. Mol. Genet., 23, 171-181.
48. Tassin, A., Laoudj-Chenivesse, D., Vanderplanck, C., Barro, M., Charron, S., Ansseau, E., Chen, Y.W., Mercier, J., Coppee, F. and Belayew, A. (2013) DUX4 expression in FSHD muscle cells: how could such a rare protein cause a myopathy? J. Cell. Mol. Med., 17, 76-89.
49. Krom, Y.D., Dumonceaux, J., Mamchaoui, K., den Hamer, B., Mariot, V., Negroni, E., Geng, L.N., Martin, N., Tawil, R., Tapscott, S.J. et al. (2012) Generation of isogenic D4Z4 contracted and noncontracted immortalmuscle cell clones fromamosaic patient: a cellularmodel for FSHD.Am. J. Pathol., 181, 1387-1401.
50. Heintzman, N.D., Hon, G.C., Hawkins, R.D., Kheradpour, P., Stark, A., Harp, L.F., Ye, Z., Lee, L.K., Stuart, R.K., Ching, C.W. et al. (2009) Histonemodifications at human enhancers reflect global cell-type-specific gene expression. Nature, 459, 108-112.
51. Heintzman, N.D., Stuart, R.K., Hon, G., Fu, Y., Ching, C.W., Hawkins, R.D., Barrera, L.O., Van Calcar, S., Qu, C., Ching, K. A. et al. (2007) Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nat. Genet., 39, 311-318.
52. Sharma,V., Harafuji,N., Belayew, A. and Chen, Y.W. (2013)DUX4 differentially regulates transcriptomes of human rhabdomyosarcoma and mouse C2C12 cells. PLoS One, 8, e64691.
53. van der Maarel, S.M., Tawil, R. and Tapscott, S.J. (2011) Facioscapulohumeral muscular dystrophy and DUX4: breaking the silence. Trends Mol. Med., 17, 252-258.
54. D'Antona, G., Brocca, L., Pansarasa, O., Rinaldi, C., Tupler, R. and Bottinelli, R. (2007) Structural and functional alterations of muscle fibres in the novel mouse model of facioscapulohumeral muscular dystrophy. J. Physiol., 584, 997-1009.
55. Deak, K.L., Lemmers, R.J., Stajich, J.M., Klooster, R., Tawil, R., Frants, R.R., Speer, M.C., van der Maarel, S.M. and Gilbert, J.R. (2007) Genotype-phenotype study in an FSHD family with a proximal deletion encompassing p13E-11 and D4Z4. Neurology, 68, 578-582.
56. Lemmers, R.J., Osborn, M., Haaf, T., Rogers, M., Frants, R.R., Padberg, G.W., Cooper, D.N., van der Maarel, S.M. and Upadhyaya, M. (2003) D4F104S1 deletion in facioscapulohumeral muscular dystrophy: phenotype, size, and detection. Neurology, 61, 178-183.
57. Tupler, R., Berardinelli, A., Barbierato, L., Frants, R., Hewitt, J. E., Lanzi, G., Maraschio, P. and Tiepolo, L. (1996) Monosomy of distal 4q does not cause facioscapulohumeral muscular dystrophy. J. Med. Genet., 33, 366-370.
58. Young, J.M., Whiddon, J.L., Yao, Z., Kasinathan, B., Snider, L., Geng,L.N.,Balog, J., Tawil,R., vanderMaarel, S.M. andTapscott, S.J. (2013)DUX4 binding to retroelements creates promoters that are active in FSHDmuscle and testis. PLoS Genet., 9, e1003947.
59. ENCODE Project Consortium. (2004) The ENCODE (ENCyclopedia Of DNA Elements) Project. Science, 306, 636-640.
60. Homma, S., Chen, J.C., Rahimov, F., Beermann, M.L., Hanger, K., Bibat, G.M., Wagner, K.R., Kunkel, L.M., Emerson, C.P. Jr. and Miller, J.B. (2012) A unique library of myogenic cells from facioscapulohumeral muscular dystrophy subjects and unaffected relatives: family, disease and cell function. Eur. J. Hum. Genet., 20, 404-410.
61. Geng, L.N., Tyler, A.E. and Tapscott, S.J. (2011) Immunodetection of human double homeobox 4. Hybridoma (Larchmt), 30, 125-130.
62. Knoepfler, P.S., Bergstrom, D.A., Uetsuki, T., Dac-Korytko, I., Sun, Y.H., Wright, W.E., Tapscott, S.J. and Kamps, M.P. (1999) A conserved motif N-terminal to the DNA-binding domains ofmyogenic bHLH transcription factors mediates cooperative DNA binding with pbx-Meis1/Prep1. Nucleic Acids Res., 27, 3752-3761.